Isotopic labeling-assisted metabolomics using LC–MS by C. Bueschl et al.
TRENDS
Isotopic labeling-assisted metabolomics using LC–MS
C. Bueschl & R. Krska & B. Kluger & R. Schuhmacher
Received: 6 July 2012 /Revised: 14 August 2012 /Accepted: 17 August 2012 /Published online: 26 September 2012
# The Author(s) 2012. This article is published with open access at Springerlink.com
Abstract Metabolomics has emerged as the latest of the so-
called “omics” disciplines and has great potential to provide
deeper understanding of fundamental biochemical processes
at the biological system level. Among recent technological
developments, LC–HRMS enables determination of
hundreds to thousands of metabolites over a wide range of
concentrations and has developed into one of the most
powerful techniques in non-targeted metabolomics. The
analysis of mixtures of in-vivo-stable isotopic-labeled sam-
ples or reference substances with un-labeled samples leads
to specific LC–MS data patterns which can be systematical-
ly exploited in practically all data-processing steps. This
includes recognition of true metabolite-derived analytical fea-
tures in highly complex LC–MS data and characterization of
the global biochemical composition of biological samples. In
addition, stable-isotopic labeling can be used for more accu-
rate quantification (via internal standardization) and identifi-
cation of compounds in different organisms.
Keywords Bioanalytical methods . Mass spectrometry .
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Metabolomics: a brief introduction
The objective of metabolomics is comprehensive, qualitative
and quantitative analysis of all the low-molecular-weight
metabolites of a living cell, organ, or whole organism [1].
The term “metabolome” has been defined by analogy with the
genome and refers to the complete set of metabolites of a
biological system [2, 3]. Thus metabolomics can be regarded
as characterization of the metabolome. Although genomes
have been sequenced for many organisms, it is currently not
possible to measure the whole metabolome of a biological
system at once, because of analytical–methodical limitations
and the highly diverse nature of the metabolites.
In this respect, two different metabolomics concepts can be
distinguished: targeted and non-targeted. In targeted
approaches, abundances of metabolites of a set of predefined
known substances are determined. Such an approach enables
absolute quantification but is usually limited to metabolites
which are available as authentic reference standards. In con-
trast, non-targeted approaches try to find mass spectrometric
features of all detectable compounds, including those un-
known at the time of sample measurement. This approach
therefore has the advantage of probing the entire metabolic
space and can obtain relative abundances of several hundreds
to thousands of known and unknown metabolites [4].
Currently, most non-targeted metabolomics studies use
liquid chromatography coupled to high-resolution mass
spectrometry (LC–HRMS). This combination enables the
detection of the highest number of metabolites and requires
only small amounts of the biological sample [5]. The com-
bination of electrospray ionization (ESI) with full-scan LC–
MS at unit resolution results in a large number of solvent-
related cluster ions and other non-metabolite-related signals
which might interfere with masses of true metabolite ions.
For this reason, low resolution ESI LC–MS is usually re-
stricted to targeted approaches in which MS–MS modes are
mostly applied. Most of the applications described in this
article were, however, used for non-targeted analysis of
biological samples using full-scan LC–HRMS.
Sample measurements with modern analytical instrumen-
tation result in huge amounts of data, which can no longer
be evaluated manually. Data-processing steps serve to
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reduce data complexity and include numerous elements, for
example feature extraction, spectrum deconvolution (i.e.,
grouping of ions which originate from the same metabolite),
retention time (Rt) alignment of chromatographic peaks
across different runs, and internal standardization for quan-
tification. The final result of data processing is a data matrix,
a table that contains all samples and analytical features (i.e.,
metabolite-derived signals). The ultimate objective of a
metabolomics study is to detect as many metabolites as
possible and to link the differently expressed metabolites
to a variety of experimental factors. Therefore, reliable
annotation and/or identification of the detected metabolites
is essential.
Despite the availability of several software tools for data
processing [6–11] and improved measurement techniques,
several limitations remain.
From the extraction of metabolite-derived analytical features
to the annotation and identification of metabolites
A first step of data processing in non-targeted metabolomics
approaches is to extract as many features as possible. The
term “feature” denotes a two dimensional bounded signal
consisting of a chromatographic peak (i.e., retention time)
and an MS peak (i.e., m/z value) [12]. The comprehensive
and reliable extraction of metabolite-derived features of true
biological origin however, remains a very difficult task. A
major limitation is the large amount of non-metabolite-
related noise and background signals. It has been estimated
that in LC–electrospray ionization–MS (LC–ESI–MS), as
little as 10 % of the signals are of true biological origin [13].
Consequently, most features are not associated with true
metabolites but can hardly be recognized as such, because
their analytical characteristics are the same as for features of
true biological origin. Furthermore, a single metabolite leads
to more than one ion species—e.g., isotopic peaks, adducts,
in-source fragments. Therefore, data processing requires the
assignment of metabolite ions and the grouping of features
into deconvoluted spectra before meaningful annotation of
metabolites can be achieved. Typically, feature abundances
are estimated by peak integration and the resulting peak
areas are used for relative quantification and comparison
of different experimental states.
After feature extraction and spectral deconvolution, an-
notation and/or identification of metabolites is essential, but
is one of the most challenging tasks of any metabolomics
experiment [14–16]. Metabolite annotation usually uses a
search for one or more molecular properties (e.g., accurate
mass, sum formula) against comprehensive databases (DB),
whereas identification also requires confirmation by mea-
surement of an authentic standard under identical analytical
conditions and/or comparison of MS–MS fragmentation
patterns.
DB search approaches seldom provide unique identifica-
tions, since usually more than one substance exists for a
particular mass or sum formula, because of the great number
of combinations of one sum formula into numerous struc-
tural formulas. Furthermore, because non-targeted metabo-
lomics experiments yield both known and unknown
metabolites, it can be expected that a significant number of
metabolites is missing from the DBs and thus remains
uncharacterized [5]. Additional MS–MS measurements are
required to provide structure information. Unfortunately,
MS–MS measurements are very labor-intensive tasks even
for only a small subset of putative metabolites and the
resulting MS–MS spectra are difficult to interpret. Further-
more, for LC–MS very few databases with authentic MS–
MS spectra are available, again reducing the number of
identifiable metabolites.
With regard to quantification of metabolites by LC–ESI–
MS, matrix effects, or signal suppression or enhancement
(SSE) (for recent review see, e.g., Refs. [17] and [18]), limit
the accuracy and reliability of quantitative measurements
within and between different measurement sequences. SSE
is caused by the presence of (endogenous or exogenous) co-
eluting components in the ion source of the mass spectrom-
eter and has been attributed to numerous mechanisms in-
cluding competition for “charges” between analytes and
interfering compounds or a change of viscosity and/or sur-
face tension of the droplets in the ion source [17, 18].
The potential of stable isotopic labeling to meet current
challenges in LC–MS-based metabolomics research
In view of these limitations, there is a strong need both for
innovative approaches to the analytical measurement of
biological samples and for the development of novel, im-
proved data-processing algorithms and their implementation
in the form of user-friendly software tools, especially for
non-targeted metabolomics.
In this respect, stable isotopic labeling (SIL) is a very
promising and increasingly popular technique in metabolo-
mics research, which is perfectly suited to be combined with
GC–MS and LC–MS. Stable isotope techniques were pre-
ceded by the use of radioactive isotopes in biochemical
research. The development of robust and sensitive GC–MS
and LC–MS instrumentation together with easier and safer
handling procedures (i.e., organizational restrictions, human
health concerns), quickly increased the use of radio isotopes
[19]. First applications of SIL in proteomics and protein
labeling demonstrated the huge advantages of this technique
[20] and researchers therefore adopted SIL in a variety of
metabolomics techniques. In this respect 13C is the most
commonly used isotope for SIL-assisted experiments, be-
cause 13C-labeled isotopologues cannot be chromatographi-
cally separated from their natural analogues (Fig. 1a).
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Moreover, carbon is a constituent of every metabolite and its
transfer between biological entities follows well known rules
[19]. Although 15N and 34S are also well suited to investiga-
tion of all nitrogen or sulfur-containing compounds and their
bio-transformation by living systems, 2H and 18O are less
frequently used for labeling of metabolites in metabolomics,
because they frequently tend to be exchanged by hydrogen
and oxygen from surrounding water. Moreover deuterated
metabolites do not always perfectly co-elute with their non-
labeled analogues [19], rendering the extent of labeling and
the results obtained from subsequent data processing difficult
to interpret. Figure 2 shows a three dimensional view of an
LC–HRMS chromatogram of the supernatant from the agri-
cultural important fungus F. graminearum, which was culti-
vated in parallel on 12C and 13C glucose medium. Identical
aliquots of the 12C and 13C supernatant were mixed and
subsequently measured using an LTQ Orbitrap XL. As one
can see in the circled area, the LC elution pattern for the 12C
(natural) and 13C-labeled metabolite ions of the same metab-
olite are identical but have a defined m/z shift (861.3835 for
the 12C ion and 897.5043 for the corresponding 13C ion).
Because 12C and 13C-labeled glucose were used for cultiva-
tion, the number of carbon atoms in this particular ion can be
calculated from the m/z difference between the two monoiso-
topic mass peaks. For this example, the m/z difference of
36.1208 suggests 36 carbon atoms for this putativemetabolite.
To further confirm that the two isotopologue ions belong
to the same putative metabolite, their carbon-isotopic distri-
butions are of interest. Whereas descending isotopic
distributions towards higher m/z values (the abundance of
natural occurring 12C is approximately 98.93 % and thus the
abundance of 13C is 1.07 %) are observed for all natural 12C
substances, 13C-labeled substances do not have descending
isotopic distributions, because their most abundant carbon
isotope is 13C and only the minority of carbon atoms are 12C
isotopes (the abundance of 13C and 12C is highly dependent on
the enrichment method and cannot be generalized in the same
way as natural carbon abundances). Thus 13C-labeled mono-
isotopic ions are not only heavier but also have ascending
isotopic distribution toward higher m/z values, because 13C
isotopes are replaced by the lighter 12C isotopes. These two
mirror symmetric isotopic distributions, which are only pres-
ent for SIL using carbon, confirm that both ions are successors
of the samemetabolite and enable the number of carbon atoms
to be easily determined. Depending on the MS instrument
used, the relative abundance of the isotopic distributions are
more or less accurately recorded. In general, TOF instruments
yield more accurate relative abundances of isotopic peaks than
Orbitrap or other FT mass analyzers, whereas the resolving
power and thus mass accuracy are higher with FT-MS instru-
ments. The theoretical isotopic-abundance pattern for a spe-
cific isotopologue in comparison with the substance’s most
intense isotopic peak is calculated by use of the formula:
P a!; s!; p!; pe!








Fig. 1 Different strategies for using SIL to assist metabolomics stud-
ies. a 13C, 15N, and 34S-enriched substances are not chromatographi-
cally separated from the corresponding natural isotopologues, thus the
non-labeled and the labeled isotopologues elute at the same retention
time with identical peak profiles. b For non-targeted annotation of an
organism’s metabolome the organism can be cultivated in parallel
using differently isotopologue-enriched nutrition sources (e.g., 12C
and 13C glucose as sole carbon source). The extracts are subsequently
mixed and measured with LC–HRMS. The resulting data pattern helps
in the extraction of true biological signals. c Absolute compound
quantification using an authentic, labeled standard or relative quantifi-
cation using a stock of globally labeled sample extract of the same
organism for inter-experiment comparison. d Metabolism experiment
using natural and fully labeled tracer substances enables metabolism
studies and greatly helps to separate products of metabolism from other
biological signals. In contrast with metabolism studies, fluxomics
experiments only spike with the labeled tracer. e Derivatisation using
non-labeled and labeled derivatisation agents enables rapid recovery of
many metabolites belonging to the same chemical groups (e.g., alco-
hols, acids …)
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where ai is the number of atoms of the ith element in the
substance, si is the number of substitutions of the most abun-
dant isotopologue with less abundant isotopes of the ith ele-
ment, pi is the isotopic purity of the used stable isotope of the
ith element, and pei is the isotopic purity of the most abundant
isotope of the ith element (e.g., the relative abundance of the
first isotopologue (13C1) compared with its
12C monoisotopic
peak for an ion having 24 carbon atoms is P([24], [1],
[0.0107], [0.9893])025.68 %. The same isotopologue having
additionally replaced one of nine oxygen atoms by 17O (nat-
ural abundances for 16O and 17O are 99.962% and 0.038%) is
P([9, 24], [1, 1], [0.0107, 0.00038], [0.9893, 0.99962])0
0.08 %). However, very low isotopic abundances (e.g., 17O,
36S, 2H …) may be of theoretical interest but, in general, do
not have to be considered practically in LC–HRMS analysis
because they are not observable with most current MS
instrumentation.
Furthermore, the mirror symmetric isotopic distributions
in the case of carbon SIL are very helpful if the substances
of interest contain heteroatoms such as sulfur, nitrogen, or
calcium. Without the SIL process, heteroatom isotopologues
cannot usually be separated from the more intense 13C
isotopologues of the natural, 12C ions even at a high MS
resolving power of 100,000. With carbon SIL additional
isotopic mass peaks originating from heteroatom isotopes
(e.g., 15N, 34S) can be observed next to the 13C ion at higher
m/z values. This benefit is very interesting for non-targeted
metabolomics because it provides further information about
the elemental composition of the detected ion species.
Apart from non-targeted metabolomics, feature extrac-
tion and annotation, SIL is also perfectly suited to absolute
quantification. Because the natural and spiked labeled
reference standard perfectly co-elute, the ratio of their peak
areas is used for absolute quantification. Furthermore, be-
cause the standard is added to the biological sample, its
concentration is known. Using the ratio of the two isotopo-
logue peak areas and the amount of reference standard,
absolute quantification of the natural isotopologue in the
sample can be achieved.
Examples of applications of SIL
All of the following SIL-assisted approaches involve anal-
ysis of mixtures of labeled and non-labeled samples and are
based on enrichment of the respective mass spectra with the
isotopic pattern of the SIL analogue(s). Depending on the
purpose of the labeling experiment (Fig. 1b–e), the degree
of isotopic enrichment, metabolic fate of the tracer(s), and
other factors, the resulting mass spectra might be affected in
different ways but all have the SIL-specific data pattern
exemplified in Fig. 1. The mass spectra might just contain
(slightly) altered relative intensities of individual isotopo-
logues or pairs of clearly separated isotopic patterns of the
natural compounds and their corresponding fully labeled
analogues.
In the following four main areas involving SIL and LC–
MS in metabolomics research will be presented with the
focus on LC–HRMS.
SIL-assisted whole metabolome studies (Fig. 1b)
For reliable extraction and annotation of putative metabo-
lites in a biological sample, non-labeled and labeled cultures
of the organism of interest are mixed and measured by use
Fig. 2 3D Plots obtained from F. graminearum. a Unprocessed LC–
HRMS full-scan chromatograms of a mixture of supernatants from
cultivation of F. graminearum on both 12C and 13C glucose. The circle
marks an ion pair (the 12C and the corresponding 13C-labeled
monoisotopic ions) originating from the same metabolite. After pro-
cessing the spectrum with MetExtract, only ions having a labeled
pendant are not removed (b). Thus, only the non-labeled ions remain
in the circled area. (3D view generated with Ref. [37])
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of LC–HRMS in the full-scan mode. Whole labeled metab-
olomes of specific organisms can be obtained when a fully
labeled substrate, for example 13C6 glucose forms the sole
carbon source of, e.g., bacteria or filamentous fungi. Such in
vivo labeling of microbes has been successfully used to
accomplish internal standardization for quantification, to
circumvent problems of signal suppression in ESI–MS
[21]. For this purpose, in-vivo-labeled samples can either
be cultured in parallel to every experimental sample and
condition and subsequently mixed with non-labeled ana-
logues, or prepared by producing a large quantity of labeled
culture with which non-labeled experimental samples can be
spiked [22, 23].
Recently, in-vivo labeling has also been extended to
plants and used to facilitate the assignment of the elemental
composition of metabolite ions by accurate mass measure-
ments in combination with database search [24, 25]. More-
over, as we have demonstrated in our own recent work, in-
vivo labeling of fungal culture samples provides a powerful
approach for the automated global extraction of all
metabolite-derived MS signals from LC–HRMS raw data
by discrimination of true metabolite-related from non-
specific analytical features [26].
SIL improves absolute quantification (Fig. 1c)
In targeted analysis, SIL reference standards can be used for
internal standardization of peak intensities in trace analysis by
use of LC–HRMS or LC–(HR)MS–MS [27, 28], making this
the most common use of SIL. Use of authentic, labeled refer-
ence standards enables easy, rapid, and absolute quantification
of the respective metabolites even in complex matrixes.
In vivo metabolism studies (Fig. 1d)
In non-targeted metabolomics, uniformly labeled substances
in combination with their natural pendants are added to
biological samples during cultivation and used as tracers to
study their metabolic fate [4]. This technique has been used
in targeted approaches to study metabolic pathways and
fluxes of the central metabolism [29, 30]. Moreover, labeled
tracers have also been used to study the bio-transformation
of secondary metabolites [31] and xenobiotics [32]. Without
use of SIL for this kind of research, searching for and
detecting these products of metabolism in complex full-
scan LC–HRMS data by non-targeted approaches would
be almost impossible. Without the use of SIL one would
have to subtract chromatograms without the spiked com-
pound from those obtained after measurement of samples
with the specific compounds added. Although possible in
principle, the latter approach results in numerous false-
positive findings because of fluctuations in MS signals from
measurement to measurement.
SIL-assisted derivatisation (Fig. 1e)
Another recently introduced SIL-based technique in combi-
nation with LC–HRMS is the use of labeled reagents for
derivatisation which enables non-targeted screening for all
compounds belonging to a specific chemical group (e.g.,
alcohols, acids …). The general workflow for a SIL deriva-
tisation step is to split the biological sample into two iden-
tical aliquots and perform derivatisation separately with
labeled and non-labeled derivatisation reagents, and mix
and measure them jointly. Thus, one not only gains all the
benefits derivatisation has but also the benefits of SIL
which, in this case, are improved metabolite feature extrac-
tion in the highly complex LC–HRMS data [33, 34] and an
estimate of the exchanged functional groups.
Despite the high potential of labeling-assisted metabolo-
mics approaches, only a few data processing tools have been
published which specifically exploit the labeling-associated
data pattern. Moreover, these tools are limited to targeted
metabolomics and fluxomics approaches. For targeted GC–
MS-based metabolomics of cell cultures, Hiller and col-
leagues published a method for study of the fate of labeled
tracer compounds through central metabolism [35]. For
targeted LC–MS studies, commercial software (IROA)
exists which has been designed to use mixtures of in-vivo
labeled and non-labeled biological culture samples to assign
differently expressed metabolites in differently treated bio-
logical samples. The software calculates and graphically
illustrates the intensity ratios of the principal ions from
predefined isotopologue signal pairs [36]. Another software
product also utilizing 13C labeling is MetMax [11], which
has been used to analyze the dynamics of CO2 uptake by
Chlamydomonas reinhardtii using GC × GC–TOF-MS. To
the best of our knowledge, the recently developed MetEx-
tract software is, to date, the only publicly available tool for
non-targeted, automated global detection of metabolite-
derived LC–HRMS signals originating from natural and
stable isotopically labeled analogues and their assignment
to true biological metabolites [26].
Although LC–MS experiments using stable isotopically
labeled compounds in combination with their naturally occur-
ring pendants is already a well established and frequently used
technique, the most limiting disadvantage is the relatively high
cost associated with enrichment of compounds with some
stable isotopes. Furthermore, a stable isotopic labeled source
which can be used for in-vivo labeling experiments or as an
internal standard may not be available commercially. Authen-
tic labeled reference standards or nutrition sources have to be
synthesized or harvested from organisms and subsequently
purified, which again is a cost-intensive exercise. For reference
standards, the second major limitation is availability because
only a very small subset of all needed reference standards are
available, which limits their advantage. Another limitation of
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SIL and whole-metabolome experiments is the requirement to
cultivate the organisms in parallel—once with the natural and
once with the stable isotope enriched nutrition source—to be
able to recover experiment or condition-specific metabolites of
the organism of interest.
Outlook
Although SIL-based analytical approaches have been devel-
oped and frequently used in both proteomics and biochemical
research for many years, the metabolomics community started
to fully exploit the potential of this technique only recently.
Considering the numerous benefits and advantages of SIL, we
expect its increased application, particularly for non-targeted
metabolomics research. Although stable isotopically labeled
compounds or biological samples are quite expensive, they
offer many benefits for analytical chemists working with LC–
MS. The unique and undistinguishable data pattern obtained
from natural and fully labeled isotopologues of a compound
drastically simplifies data processing. Furthermore, in target
analysis the addition of labeled authentic standards enables
absolute quantification of substances in biological samples.
For non-targeted metabolomics SIL-based LC–HRMS
approaches enable global data extraction and feature annota-
tion for true metabolites and can help to improve precision in
relative quantification.With further improved analytical instru-
mentation and customized data-processing software for SIL-
derived data patterns, this technique has the potential to be of
crucial importance in the new discipline of metabolomics.
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